InvestorsHub Logo
Followers 21
Posts 4511
Boards Moderated 0
Alias Born 12/18/2009

Re: None

Saturday, 10/23/2010 12:05:50 PM

Saturday, October 23, 2010 12:05:50 PM

Post# of 129051
Py attention newbs - Latest substantial news relayed to us:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=55448296

2 good bits and a nice realization of their FDA submittal anticipation

1.This strain and its formulated products will be available for dispensary sale in the next quarter.
This is the first I've seen of market branding or positioning CS as a brand with a specific strain. Good job

2. Cannabis Science and its colleagues have been assembling a petition to the Colorado Department of Health and Environment to gain acceptance for medical cannabis use for PTSD under the state regulations.
This is nice to see our company positioning itself on a frontline. Good job

And it was very nice to let us know who is consulting them in the conceptual stages of FDA applications.

Quote:
is in the planning phase with the CBR International Group…..


and that coupled with

Quote:
Our goal is to coordinate clinical partnerships and patient care with our standardized product line in Colorado, and to gather data that supports the use of cannabis extracts for this indication before pursuing a new drug application.


Tells me that they have a map.
and it starts in Q1 2011


In summary, I interpret:
we are perfecting a perfect and predictable strain in partnership / with Rockbrook
1Q 2011 or sooner this strain will be on shelfs

I hope that they take advantage of the shoulder to shoulder with D'Angello from Harborside @ the MJ conference - (the countries largest & most profitable dispensary) and we get shelf space their.

After the CBIS strain is tried and true the FDA submittal process will be launched

I believe CBIS will continue to create hybrid strains that will target specific user needs
Value will be perpetual with the highest of quality & CBIS brand products



Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.